User profiles for Annalan M D Navaratnam
 | Annalan MD NavaratnamUniversity of Cambridge Verified email at cam.ac.uk Cited by 1595 |
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Vaccines based on the spike glycoprotein of SARS-CoV-2 are being rolled out globally to
control transmission and limit morbidity and mortality due to COVID-19. Current evidence …
control transmission and limit morbidity and mortality due to COVID-19. Current evidence …
Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis
…, JC Sousa-Figueiredo, AMD Navaratnam - Expert Review of Anti …, 2013 - Taylor & Francis
Preventive chemotherapy campaigns against schistosomiasis have progressively scaled-up
during the last decade, administering single standard dose praziquantel (40 mg/kg) …
during the last decade, administering single standard dose praziquantel (40 mg/kg) …
[HTML][HTML] Prevalence and characteristics of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and …
F Miller, V Nguyen, AMD Navaratnam… - The Pediatric …, 2022 - journals.lww.com
This work was supported by the Medical Research Council [grant numbers MC_PC19070
and MR/V028375/1, and MR/N013867/1 to Miss Miller] and the Wellcome Trust [grant number …
and MR/V028375/1, and MR/N013867/1 to Miss Miller] and the Wellcome Trust [grant number …
[HTML][HTML] Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children
…, M Betson, A Atuhaire, M Arinaitwe, AMD Navaratnam… - 2012 - journals.plos.org
Background In 2012 the WHO formally recognised that infants and preschool children are at
significant risk of schistosomiasis and qualify for treatment with praziquantel (PZQ). …
significant risk of schistosomiasis and qualify for treatment with praziquantel (PZQ). …
[HTML][HTML] Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study
…, E Fragaszy, V Nguyen, AMD Navaratnam… - Nature …, 2022 - nature.com
Vaccination constitutes the best long-term solution against Coronavirus Disease-2019;
however, vaccine-derived immunity may not protect all groups equally, and the durability of …
however, vaccine-derived immunity may not protect all groups equally, and the durability of …
Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort …
Introduction The coronavirus (COVID-19) pandemic has caused significant global mortality
and impacted lives around the world. Virus Watch aims to provide evidence on which public …
and impacted lives around the world. Virus Watch aims to provide evidence on which public …
[HTML][HTML] Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community …
AMD Navaratnam, M Shrotri, V Nguyen… - International Journal of …, 2022 - Elsevier
Objectives Seroprevalence studies can provide a measure of SARS-CoV-2 cumulative
incidence, but a better understanding of spike and nucleocapsid (anti-N) antibody dynamics …
incidence, but a better understanding of spike and nucleocapsid (anti-N) antibody dynamics …
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of …
Background SARS-CoV-2 vaccines stimulate production of antibodies targeting the spike
protein (anti-S). The level of antibodies following vaccination and trajectories of waning may …
protein (anti-S). The level of antibodies following vaccination and trajectories of waning may …
[HTML][HTML] SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort
A range of studies globally demonstrate that the effectiveness of SARS-CoV-2 vaccines wane
over time, but the total effect of anti-S antibody levels on risk of SARS-CoV-2 infection and …
over time, but the total effect of anti-S antibody levels on risk of SARS-CoV-2 infection and …
[HTML][HTML] Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and …
…, E Fragaszy, C Geismar, J Kovar, AMD Navaratnam… - Vaccine, 2021 - Elsevier
Background Vaccination intention is key to the success of any vaccination programme,
alongside vaccine availability and access. Public intention to take a COVID-19 vaccine is high in …
alongside vaccine availability and access. Public intention to take a COVID-19 vaccine is high in …